New combo therapy aims to shrink untreatable liver tumors

NCT ID NCT07180459

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 30 times

Summary

This study tests a new way to treat liver cancer that cannot be removed by surgery. Doctors will use tiny drug-coated beads to block blood flow to the tumor and combine this with a targeted drug called Donafenib. The goal is to see if this approach can shrink tumors and help people live longer. About 118 adults with unresectable liver cancer will take part.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Deng zhou People's Hospital

    Nanyang, Henan, China

  • First People's Hospital of Shangqiu

    Shangqiu, Henan, China

  • Huai He Hospital of Henan University

    Kaifeng, Henan, China

  • Jiangxi Provincial People's Hospitail

    Nanchang, Jiangxi, China

  • Luo He Central Hospital

    Luohe, Henan, China

  • Luo Yang Central Hospital

    Luoyang, Henan, China

  • People's Hospital of Kaiyang County

    Guiyang, Guizhou, China

  • Second People's Hospital of Jiaozuo

    Jiaozuo, China

  • The Second Affiliated Hospital of Hainan Medical Universsity

    Haikou, Hainan, China

  • Zhou Kou Central Hospital

    Zhoukou, Henan, China

Conditions

Explore the condition pages connected to this study.